Form 8-K - Current report:
SEC Accession No. 0001477932-24-001570
Filing Date
2024-03-29
Accepted
2024-03-28 20:20:05
Documents
15
Period of Report
2024-03-29
Items
Item 5.01: Changes in Control of Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K blms_8k.htm   iXBRL 8-K 19027
  Complete submission text file 0001477932-24-001570.txt   131885

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA blms-20240329.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE blms-20240329_lab.xml EX-101.LAB 13171
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE blms-20240329_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blms-20240329_pre.xml EX-101.PRE 8249
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blms-20240329_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT blms_8k_htm.xml XML 3535
Mailing Address 701 ANACAPA STREET, SUITE C SANTA BARBARA CA 93101
Business Address 701 ANACAPA STREET, SUITE C SANTA BARBARA CA 93101 805-222-6330
BLOOMIOS, INC. (Filer) CIK: 0001138608 (see all company filings)

EIN.: 874696476 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50026 | Film No.: 24801608
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)